Najmiatul Fitria

Najmiatul Fitria

Auto-generated profile, based on publicly available information

Najmiatul Fitria

Universitas Andalas

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2018 in The European Journal of Health Economics
Verified
Journal Article
Open access
PDF file
NFNajmiatul Fitria
Najmiatul Fitria
AAAntoinette D. I. van Asselt
Antoinette D. I. van Asselt
MPMaarten J. Postma
Maarten J. Postma
Objective Timely screening for hyperglycaemia in pregnancy using a simple glucose test enhances early detection and control of gestational diabetes mellitus (GDM). The aim of this study was to provide an overview of the evidence on the cost-effectiveness of identification and/or treatment of GDM. Methods We conducted a systematic review using three electronic databases (PubMed, EMBASE, and Cochrane) of cost-effectiveness studies of GDM screening and treatment published during 2000–2017. Results The initial search discovered 287 references (PubMed 86, EMBASE 195, Cochrane library 6) of which six full articles were included in the review. Two articles were model-based analysis and the remaining four were trial based. Two studies demonstrated favorable cost-effectiveness of intensified management of mild GDM. In the other included studies, neither screening nor treatment of GDM was shown to be cost effective, although results varied with the particular outcome measures used and the assumptions that where applied. Conclusion Neither screening nor treating GDM seems to be convincingly cost-effective from the studies reviewed. However, all studies were done in high-income countries with obviously different health systems than low-/middle-income countries (LMIC) have. Since detection of GDM may be relatively poor in LMIC, screening might be more worthwhile in these countries. Comprehensive research is necessary in LMIC, including the potential outcomes of assessing its cost-effectiveness. Favorable cost-effectiveness could help in bridging the need for and access to increased diabetes screening in early pregnancy in these countries.

1 January 2019 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
FGFajri Gafar
Fajri Gafar
HAHelmi Arifin
Helmi Arifin
YJYusri D. Jurnalis
Yusri D. Jurnalis
FYFinny F. Yani
Finny F. Yani
NFNajmiatul Fitria
Najmiatul Fitria
BWBob Wilffert
Bob Wilffert
Background: As one of the most frequent and serious adverse reactions during tuberculosis (TB) treatment, antituberculosis drug-induced liver injury (ATLI) in children has been studied insufficiently compared with adults. We aimed to determine the incidence and risk factors of ATLI in children during the first 2 months of TB therapy. Methods: A total of 41 children with TB and treated with first-line anti-TB drugs were prospectively followed-up for the development of ATLI. Liver function tests were performed at baseline and after 2 weeks of therapy. Subsequent tests were conducted at 4, 6 and 8 weeks if the initial 2-week measurement was abnormal or if symptoms of hepatotoxicity were reported. Results: ATLI was detected in 11 (27%) patients within 14 to 42 days from the start of therapy, with most of them (54%) occurred after 2 weeks. TB treatment was stopped immediately in 6 of 11 patients who developed ATLI, and no recurrent hepatotoxicity after drug reintroductions in these patients. Univariate analysis showed that ATLI was significantly associated with TB meningitis (P < 0.01), hypoalbuminemia (P < 0.05) and hepatotoxic comedications (P < 0.01). Age, sex, nutritional status, HIV status and baseline liver function abnormalities were not associated with ATLI. Multivariate analysis identified hypoalbuminemia and hepatotoxic comedications (both P < 0.1) tend to be independently associated with ATLI. Conclusions: Children with hypoalbuminemia and use of hepatotoxic comedications are suggested to be monitored closely for the development of ATLI.

1 January 2023 in Digital Health
Verified
Journal Article
Open access
NFNajmiatul Fitria
Najmiatul Fitria
LILusiana Idrus
Lusiana Idrus
APAyuthya Rizky Putri
Ayuthya Rizky Putri
YSYelly Oktavia Sari
Yelly Oktavia Sari
Introduction: Diabetes mellitus is a degenerative disease that obliges patients to take continuous healthcare services. During a pandemic situation, all access to healthcare facilities becomes limited. A web-based integrated electronic-healthcare system (IeHS) study was used to overcome this problem. This study aimed to describe patients’ ability to access and understand this web-based application. Method: An observational study using a web-based IeHS took place in Muara Tebo, Indonesia, in 2021. A total of 82 outpatients with diabetes mellitus participated in this study. These patients belonged to local community-based diabetes mellitus. Only adult patients accustomed to using smartphones were invited to participate in this study. All participants were taught to access the web-based application through video recordings. They were asked to fill out the form regarding their understanding of the web-based integrated e-healthcare application. This form was sent online. Results: From the calculation of the usability scale, the results show that patients have not been able to take advantage of this application in life (the system usability scale (SUS) score 63.38). There is no significant difference between patients’ characteristics and the SUS score. Conclusion: Participants’ condition in this study reflects the general state of outpatients. The ability of these participants to access an internet-based application was related to their education level. This condition becomes a challenge for policymakers to improve local human resources to increase their health literacy.

11 January 2021 in Journal of Genetic Engineering and Biotechnology
Verified
Journal Article
Open access
PDF file
DEDesriani
Desriani
AZAzamris
Azamris
SGShabrina S. Ghaissani
Shabrina S. Ghaissani
SKSenja R. Kinanti
Senja R. Kinanti
MWMuhammad A. Warisman
Muhammad A. Warisman
NFN. Fitria
N. Fitria
Breast cancer is a disease in which cell grows rapidly forming a mass in the breast. HER2 polymorphisms Ile655Val have been studied as biomarkers for breast cancer and may comprise a risk factor of cardiac toxicity for breast cancer-consuming trastuzumab. Aim of work: In this study, we developed a simple, low cost, and rapid test to detect polymorphism at HER2 gene using SYBR Green I-based melting curve method. In this report, we performed allelic discrimination with real-time temperature melting (Tm) Shift SYBR Green I-based melting curve method. The melting profiles of amplified DNA HER-2 Ile655Val and its characteristics were analyzed. Tm value of HER2 GG and AA alleles were 85 ± 0.14 °C and 82.5 ± 0.23 °C, respectively, while cycle threshold (Ct) value of GG, AG, and AA alleles were 19.6 ± 0.27, 22.5 ± 0.23, 18.6 ± 0.22 correspondingly; furthermore, no template control has shown consisting Ct value at 31.18 ± 0.27. The developed methods’ characteristics were optimum annealing at 62 °C and Kappa coefficient value 1 with the mean almost consistent with PCR-sequencing. The coefficient of variability for intra-assay of GG, AG, and AA was in the range of 0.2–1%, while the coefficient of variability for inter-assay for each were in the range 0.7–1%. Further, based on PCR, shelf-life assay has shown stability for 3 months of storage observation. This approach may be considered as simple, rapid, and low cost supporting the rapid study of HER2 epidemiology. Furthermore, the developed methods potentially facilitate clinicians in dealing with breast cancer patients, especially in considering about the cardiotoxicity effect of trastuzumab.

9 April 2023 in Jurnal Sains Farmasi & Klinis
Verified
Journal Article
Open access
PDF file
NFNajmiatul Fitria
Najmiatul Fitria
LLLailaturrahmi Lailaturrahmi
Lailaturrahmi Lailaturrahmi
YSYelly Oktavia Sari
Yelly Oktavia Sari
FAFahira Tri Anata
Fahira Tri Anata
KHKhairatul Husnia
Khairatul Husnia
Adherence Assessment on Hypertension Therapy Using The Pill Count Method In Lubuk Kilangan Health Center, Indonesia

15 February 2024 in International Journal of Applied Pharmaceutics
Verified
Journal Article
Open access
PDF file
RYRahmi Yosmar
Rahmi Yosmar
ESEugenia Shepany
Eugenia Shepany
NFNajmiatul Fitria
Najmiatul Fitria
Objective: Type 2 diabetes mellitus (DM) is a disease that is the leading cause of blindness, heart disease, and kidney failure. Geriatric patients with type 2 DM and complications require multiple medications (polypharmacy), contributing to drug-drug interactions (DDIs). DDIs can affect the clinical outcome of patients. This study aims to analyze potential drug-drug interactions based on the mechanism and severity, determine the relationship between the number of medications and potential drug interaction, and determine the relationship between polypharmacy and the severity of clinical outcomes. Methods: This was an analytical observational with retrospective data collection through patient medical records of hospitalized patients treated with an antidiabetic and one or more other drugs that met the inclusion criteria, involving 81 patients using total sampling. Results: The result showed that out of 81 patients, there were 59 patients who potentially experienced drug-drug interactions (72.8%) with a total of 162 cases of drug interactions, and the most prevalent interaction mechanism was pharmacodynamic (84.0%) with a moderate severity level (57.4%). There was a significant relationship between the number of medications and potential drug-drug interactions (p0.05). Conclusion: An increase in the number of drugs is a predictor of drug interactions. Although drug interactions may theoretically occur, not all interactions will significantly affect patients.